• Proceedings of the Korean Nuclear Society Conference
• /
• 2004.10a
• /
• pp.1255-1256
• /
• 2004

• Proceedings of the Korean Society of Veterinary Clinics Conference
• /
• 2008.10a
• /
• pp.188-188
• /
• 2008

• Proceedings of the Korean Society of Embryo Transfer Conference
• /
• 2003.10a
• /
• pp.105-105
• /
• 2003

• Proceedings of the Korean Society of Embryo Transfer Conference
• /
• 2003.10a
• /
• pp.106-106
• /
• 2003

• 대한핵의학회:학술대회논문집
• /
• 2002.11a
• /
• pp.26.2-26.2
• /
• 2002

• Proceedings of the Korean Society of Applied Pharmacology
• /
• 1996.04a
• /
• pp.30-35
• /
• 1996

• Proceedings of the Korean Society of Veterinary Clinics Conference
• /
• 2008.05a
• /
• pp.116-116
• /
• 2008

• 대한핵의학회:학술대회논문집
• /
• 2000.05a
• /
• pp.52.2-52.2
• /
• 2000

• Clinical Endoscopy
• /
• v.56 no.2
• /
• pp.261-261
• /
• 2023

• Journal of Biomedical Engineering Research
• /
• v.30 no.2
• /
• pp.122-128
• /
• 2009

Cancer serum biomarkers have advanced our ability to more accurately predict tumor classification, prognostic/metastatic potential, and response potential to novel chemotherapies. Serum amyloid A (SAA) and Vascular endothelial growth factor (VEGF) have potential utility as a serum biomarker for lung cancer. Quantum dots, nanometer-sized crystals, have a high quantum yield, sensitivity, and pronounced photostability. The properties of quantum dots can be efficiently applied to the detection of serum biomarkers in immunoassays as fluorescent probe. We used quantum dots as fluorescent probes in immunoassays and attempted to detect serum amyloid A and vascular endothelial growth factor as serum biomarkers of lung cancer. This fluorescence immunoassay based on the properties of quantum dots is applicable to the detection of serum biomarkers for lung cancer. The fluorescence immunoassay with quantum dots should allow the efficient and specific detection of serum amyloid A (SAA) for the possible diagnosis of lung cancer.